Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Common gene patterns may cause skin autoimmune diseases.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

More precise, personalized therapies are needed for autoimmune diseases.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Fever and rash can be early signs of lupus.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Young patients are more likely to develop autoimmune diseases, while elderly patients are more prone to organ failure after DRESS.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Hair loss is mainly caused by hormones, autoimmune issues, and chemotherapy, and needs more research for treatments.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.